Page 320 - Tata_Chemicals_yearly-reports-2021-22

Integrated Annual Report 2021-22

(c) The following tables set out the funded status and amounts recognised in the Group’s Consolidated Financial Statements
as at March 31, 2022 and March 31, 2021 for the Defined benefits plans:
(i) Changes in the defined benefit obligation: ` in crore
Year ended Year ended
Particulars March 31, 2022 March 31, 2021
Funded Unfunded Funded Unfunded
At the beginning of the year 5,605.86 259.90 5,096.82 262.64
Current service cost 49.11 5.52 48.45 5.79
Interest cost 147.34 13.14 148.90 12.90
Remeasurements (gain)/loss
Actuarial (gain) / loss arising from:
- Changes in financial assumptions (344.06) (15.94) 420.46 (5.64)
- Changes in demographic assumptions (14.44) 0.13 (17.03) 0.74
- Experience adjustments 51.13 (8.78) (34.03) (3.30)
Benefits paid (348.49) (12.97) (233.95) (10.08)
Transfer in/(out) - - 0.06 -
Past service cost 0.04 11.54 15.35 -
Exchange fluctuations 35.58 3.33 160.83 (3.15)
At the end of the year 5,182.07 255.87 5,605.86 259.90

(ii) Changes in the fair value of plan assets: ` in crore
Year ended Year ended
Particulars March 31, 2022 March 31, 2021
Funded Unfunded Funded Unfunded
At the beginning of the year 4,486.05 - 3,925.91 -
Interest on plan assets 119.28 - 112.03 -
Administrative expenses (11.90) - (10.56) -
Remeasurement (gain)/loss
Annual return on plan assets less interest on plan assets 62.27 - 524.32 -
Contributions 25.59 - 32.72 -
Benefits paid (348.49) - (233.95) -
Transfer in/(out) - - 0.06 -
Exchange fluctuations 26.74 - 135.52 -
Value of plan assets at the end of the year 4,359.54 - 4,486.05 -
Liability (net) 822.53 255.87 1,119.81 259.90

318